MAIANYSEPharmaceutical PreparationsFiscal year ends December 31
MAIA Biotechnology, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$1.07−0.03 (-2.73%)
Close on Oct 19, 2026
- Market cap
- $65.05M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
MAIA Biotechnology has not reported a dividend
No dividend per share appears in MAIA Biotechnology's annual filings since fiscal 2020.